C. Lumeng, J. Bodzin, and A. Saltiel, Obesity induces a phenotypic switch in adipose tissue macrophage polarization, Journal of Clinical Investigation, vol.117, issue.1, pp.175-184, 2007.
DOI : 10.1172/JCI29881

P. Tontonoz and B. Spiegelman, Fat and Beyond: The Diverse Biology of PPAR??, Annual Review of Biochemistry, vol.77, issue.1, pp.289-312, 2008.
DOI : 10.1146/annurev.biochem.77.061307.091829

J. Odegaard, R. -. Gonzalez, R. Goforth, M. Morel, C. Subramanian et al., Macrophage-specific PPAR?? controls alternative activation and improves insulin resistance, Nature, vol.292, issue.7148, pp.1116-1120, 2007.
DOI : 10.1038/nature05894

V. Bourlier, A. Zakaroff-girard, A. Miranville, D. Barros, S. Maumus et al., Remodeling Phenotype of Human Subcutaneous Adipose Tissue Macrophages, Circulation, vol.117, issue.6, pp.806-815, 2008.
DOI : 10.1161/CIRCULATIONAHA.107.724096

URL : https://hal.archives-ouvertes.fr/inserm-00480230

A. Mantovani, P. Allavena, S. Sozzani, A. Vecchi, and M. Locati, Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors, Seminars in Cancer Biology, vol.14, issue.3, pp.155-160, 2004.
DOI : 10.1016/j.semcancer.2003.10.001

D. Mosser and J. Edwards, Exploring the full spectrum of macrophage activation, Nature Reviews Immunology, vol.117, issue.12, pp.958-969, 2008.
DOI : 10.1038/nri2448

S. Khovidhunkit, T. Suwantuntula, S. Thaweboon, S. Mitrirattanakul, and U. Chomkhakhai, Xerostomia, hyposalivation, and oral microbiota in type 2 diabetic patients: a preliminary study, J Med Assoc Thai, vol.92, issue.9, pp.1220-1228, 2009.

P. Lutsey, J. Pankow, A. Bertoni, M. Szklo, and A. Folsom, Serological evidence of infections and Type 2 diabetes: the Multiethnic Study of Atherosclerosis, Diabetic Medicine, vol.25, issue.2, pp.149-152, 2009.
DOI : 10.1111/j.1464-5491.2008.02632.x

D. Macedo, N. Oliveira, A. Farias, V. Silva, and A. Wilheim, Esophagitis caused by Candida guilliermondii in diabetes mellitus: first reported case, Med Mycol, pp.1-4, 2010.

V. Viswanathan, J. Jasmine, C. Snehalatha, and A. Ramachandran, Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients, J Assoc Physicians India, vol.50, pp.1013-1016, 2002.

M. Belazi, A. Velegraki, A. Fleva, I. Gidarakou, and L. Papanaum, Candidal overgrowth in diabetic patients: potential predisposing factors, Mycoses, vol.32, issue.3, pp.192-196, 2005.
DOI : 10.1016/0003-9969(80)90075-8

N. Soysa, L. Samaranayake, and A. Ellepola, Diabetes mellitus as a contributory factor in oral candidosis, Diabetic Medicine, vol.10, issue.5, pp.455-459, 2006.
DOI : 10.1016/1056-8727(93)90025-T

A. Coste, M. Dubourdeau, M. Linas, S. Cassaing, and J. Lepert, PPAR?? Promotes Mannose Receptor Gene Expression in Murine Macrophages and Contributes to the Induction of This Receptor by IL-13, Immunity, vol.19, issue.3, pp.329-339, 2003.
DOI : 10.1016/S1074-7613(03)00229-2

A. Coste, C. Lagane, C. Filipe, H. Authier, and A. Gales, IL-13 Attenuates Gastrointestinal Candidiasis in Normal and Immunodeficient RAG-2-/- Mice via Peroxisome Proliferator-Activated Receptor-?? Activation, The Journal of Immunology, vol.180, issue.7, pp.4939-4947, 2008.
DOI : 10.4049/jimmunol.180.7.4939

URL : https://hal.archives-ouvertes.fr/hal-00283071

A. Gales, A. Conduche, J. Bernad, L. Lefevre, and D. Olagnier, PPAR?? Controls Dectin-1 Expression Required for Host Antifungal Defense against Candida albicans, PLoS Pathogens, vol.31, issue.1, p.1000714
DOI : 10.1371/journal.ppat.1000714.g007

A. Coste, M. Linas, S. Cassaing, J. Bernad, and S. Chalmeton, A sub-inhibitory concentration of amphotericin B enhances candidastatic activity of interferon-gamma- and interleukin-13-treated murine peritoneal macrophages, Journal of Antimicrobial Chemotherapy, vol.49, issue.5, pp.731-740, 2002.
DOI : 10.1093/jac/dkf011

A. Berry, P. Balard, A. Coste, D. Olagnier, and C. Lagane, IL-13 induces expression of CD36 in human monocytes through PPARgamma activation, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00166681

S. Aleshin, S. Grabeklis, T. Hanck, M. Sergeeva, and G. Reiser, Peroxisome Proliferator-Activated Receptor (PPAR)-?? Positively Controls and PPAR?? Negatively Controls Cyclooxygenase-2 Expression in Rat Brain Astrocytes through a Convergence on PPAR??/?? via Mutual Control of PPAR Expression Levels, Molecular Pharmacology, vol.76, issue.2, pp.414-424, 2009.
DOI : 10.1124/mol.109.056010

J. Fernandez-real and J. Pickup, Innate immunity, insulin resistance and type 2 diabetes, Trends in Endocrinology & Metabolism, vol.19, issue.1, pp.10-16, 2008.
DOI : 10.1016/j.tem.2007.10.004

M. Shaul, G. Bennett, K. Strissel, A. Greenberg, and M. Obin, Dynamic, M2-Like Remodeling Phenotypes of CD11c+ Adipose Tissue Macrophages During High-Fat Diet-Induced Obesity in Mice, Diabetes, vol.59, issue.5, pp.1171-81, 2010.
DOI : 10.2337/db09-1402

M. Zeyda, D. Farmer, J. Todoric, O. Aszmann, and M. Speiser, Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production, International Journal of Obesity, vol.18, issue.9, pp.31-1420, 2007.
DOI : 10.1038/sj.ijo.0803632

M. Nguyen, S. Favelyukis, A. Nguyen, D. Reichart, and P. Scott, A Subpopulation of Macrophages Infiltrates Hypertrophic Adipose Tissue and Is Activated by Free Fatty Acids via Toll-like Receptors 2 and 4 and JNK-dependent Pathways, Journal of Biological Chemistry, vol.282, issue.48, pp.35279-92, 2007.
DOI : 10.1074/jbc.M706762200

F. Martinez, A. Sica, A. Mantovani, and M. Locati, Macrophage activation and polarization, Frontiers in Bioscience, vol.13, issue.13, pp.453-461, 2008.
DOI : 10.2741/2692

A. Vidal-puig, M. Jimenez-linan, B. Lowell, A. Hamann, and E. Hu, Regulation of PPAR gamma gene expression by nutrition and obesity in rodents., Journal of Clinical Investigation, vol.97, issue.11, pp.2553-2561, 1996.
DOI : 10.1172/JCI118703

J. Zhou, K. Wilson, and J. Medh, Genetic analysis of four novel peroxisome proliferator activated receptor-?? splice variants in monkey macrophages, Biochemical and Biophysical Research Communications, vol.293, issue.1, pp.274-283, 2002.
DOI : 10.1016/S0006-291X(02)00138-9

B. Necela, W. Su, and E. Thompson, Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor ?? and nuclear factor-??B in macrophages, Immunology, vol.27, issue.3, pp.344-58, 2008.
DOI : 10.1111/j.1365-2567.2008.02849.x

M. Zhou, R. Wu, W. Dong, A. Jacob, and P. Wang, Endotoxin downregulates peroxisome proliferator-activated receptor-?? via the increase in TNF-?? release, AJP: Regulatory, Integrative and Comparative Physiology, vol.294, issue.1, pp.84-92, 2008.
DOI : 10.1152/ajpregu.00340.2007

H. Cho, W. Gladwell, X. Wang, B. Chorley, and D. Bell, Nrf2-Regulated PPAR{gamma} Expression is Critical to Protection Against Acute Lung Injury in Mice, Am J Respir Crit Care Med, 2010.

T. Jiang, Z. Huang, Y. Lin, Z. Zhang, and D. Fang, The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy, Diabetes, vol.59, issue.4, pp.850-60, 2010.
DOI : 10.2337/db09-1342

A. Szanto and L. Nagy, The many faces of PPARgamma: anti-inflammatory by any means?, Immunobiology, vol.213, pp.9-10, 2008.

J. Fruchart, Peroxisome proliferator-activated receptor-alpha (PPAR??): At the crossroads of obesity, diabetes and cardiovascular disease, Atherosclerosis, vol.205, issue.1, pp.1-8, 2009.
DOI : 10.1016/j.atherosclerosis.2009.03.008

C. Forsyth, E. Plow, and L. Zhang, Interaction of the fungal pathogen Candida albicans with integrin CD11b/CD18: recognition by the I domain is modulated by the lectin-like domain and the CD18 subunit, J Immunol, vol.161, issue.11, pp.6198-6205, 1998.

G. Caimi, M. Montana, F. Ferrara, F. Porretto, and M. Musso, Polymorphonuclear leukocyte integrin pattern, at baseline and after activation, in type 2 diabetic subjects with macrovascular complications, Acta Diabetologica, vol.40, issue.1, pp.14-19, 2003.
DOI : 10.1007/s005920300003

F. Chang and M. Shaio, Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus, Diabetes Research and Clinical Practice, vol.28, issue.2, pp.137-146, 1995.
DOI : 10.1016/0168-8227(95)00168-8

J. Greenfield and L. Campbell, Relationship Between Inflammation, Insulin Resistance and Type 2 Diabetes: Cause or Effect?, Current Diabetes Reviews, vol.2, issue.2, pp.195-211, 2006.
DOI : 10.2174/157339906776818532

X. Ma, Z. Chang, M. Qin, Y. Sun, and H. Huang, Decreased expression of complement regulatory proteins, CD55 and CD59, on peripheral blood leucocytes in patients with type 2 diabetes and macrovascular diseases, Chin Med J (Engl), vol.122, issue.18, pp.2123-2128, 2009.

C. Fernandes-santos, R. Carneiro, L. De-souza-mendonca, M. Aguila, and C. Mandarim-de-lacerda, Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet, Nutrition, vol.25, issue.7-8, pp.7-8, 2009.
DOI : 10.1016/j.nut.2008.12.010

H. Kim, M. Haluzik, O. Gavrilova, S. Yakar, and J. Portas, Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes, Diabetologia, vol.278, issue.12, pp.2215-2225, 2004.
DOI : 10.1007/s00125-004-1581-6

B. Gantner, R. Simmons, S. Canavera, S. Akira, and D. Underhill, Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2, The Journal of Experimental Medicine, vol.63, issue.9, pp.1107-1117, 2003.
DOI : 10.1093/infdis/163.5.1154